GoodRx Falls after CVS Annouces Affordable Drug Program
$GoodRx(GDRX.US$ fell Tuesday after raising 13% last week. The drop followed $CVS Health(CVS.US$ investor day. The firm relased 2024 revenue guidance Tuesday morning, announcing a competitive prescription drug product called CostVantage, and a second program called TrueCost.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment